FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080148 [Registered on: 07/02/2025] Trial Registered Prospectively
Last Modified On: 04/02/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Evaluation of relief of pain after operation between two types of regional anaesthesia technique (external oblique intercostal block versus oblique subcostal transversus abdominis plane block) for a special type of cut in the abdominal wall known as modified Makuuchi incision 
Scientific Title of Study   External oblique intercostal block vs Oblique subcostal transversus abdominis plane block for postoperative pain management in surgeries with modified Makuuchi incision- A Randomised Controlled Study (OBLIQUES 
Trial Acronym 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Angshuman Rudrapal 
Designation  Associate Consultant 
Affiliation  Tata Medical Center 
Address  Department of Onco-anaesthesia, Tata Medical Center, 14, Major Arterial Road, New Town, Kolkata-700160
-
North Twentyfour Parganas
WEST BENGAL
700160
India 
Phone  7980006561  
Fax    
Email  angshunitya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Angshuman Rudrapal 
Designation  Associate Consultant 
Affiliation  Tata Medical Center 
Address  Department of Onco-anaesthesia, Tata Medical Center, 14, Major Arterial Road, New Town, Kolkata-700160
-
North Twentyfour Parganas
WEST BENGAL
700160
India 
Phone  7980006561  
Fax    
Email  angshunitya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Angshuman Rudrapal 
Designation  Associate Consultant 
Affiliation  Tata Medical Center 
Address  Department of Onco-anaesthesia, Tata Medical Center, 14, Major Arterial Road, New Town, Kolkata-700160
-
North Twentyfour Parganas
WEST BENGAL
700160
India 
Phone  7980006561  
Fax    
Email  angshunitya@gmail.com  
 
Source of Monetary or Material Support  
Department of Onco-anaesthesia,Tata Medical Center, 14,Major Arterial Road, New Town, Kolkata-700160 
 
Primary Sponsor  
Name  Angshuman Rudrapal 
Address  Department of Onco-anaesthesia, Tata Medical Center, 14,Major Arterial Road, New Town, Kolkata-700160 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Angshuman Rudrapal  Tata Medical Center  Operation theatre, Phase 1, Department of Onco-anaesthesia, Tata Medical Center, 14,Major Arterial Road, New Town, Kolkata-700160
North Twentyfour Parganas
WEST BENGAL 
7980006561

angshunitya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tata Medical Center- Institutional Review Board  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K87||Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  External Oblique Intercostal (EOI) block   Ultrasound guided identification of plane between External oblique and Intercostal muscles, just medial to anterior axillary line, will inject 15 ml 0.2% Ropivacaine and then introduce the catheter and inject 5 ml 0.2% Ropivacaine through the catheter. In the post operative period 0.2% Ropivacaine 5-6 ml/hour will be given as continuous infusion till 72 hours after surgery. And then the catheter will be removed. 
Comparator Agent  Oblique Subcostal TAP (OSTAP) block   Ultrasound guided identification of plane between internal oblique and transversus abdominis muscle in subcostal area, will inject 15 ml 0.2% Ropivacaine and then introduce the catheter and inject 5 ml 0.2% Ropivacaine through the catheter. In the post operative period 0.2% Ropivacaine 5-6 ml/hour will be given as continuous infusion till 72 hours after surgery. And then the catheter will be removed. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Patients undergoing elective abdominal surgeries with modified Makuuchi incision or reversed L- shaped incision.
2. American Society of Anaesthesiology Physical Score (ASA-PS) score of I - III
 
 
ExclusionCriteria 
Details  Patients requiring postoperative mechanical ventilation.
Contraindications to spinal anaesthesia
Contraindications to study medication
Documented obstructive sleep apnea
Patients with life threatening arrhythmias
Patients with left ventricular ejection fraction less than 40%
Coagulopathy
Pre Existing neurological illness
Significant liver dysfunction (liver enzymes more than 3 times normal)
Significant renal dysfunction (creatinine more than 2 times normal)
Psychiatric illness
Opioid abuse
Patients receiving systemic opioids for chronic pain within last 30 days
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
24 hours intravenous morphine consumption in mg  24 hours intravenous morphine consumption in mg 
 
Secondary Outcome  
Outcome  TimePoints 
1. 48-hours and 72-hours intravenous morphine consumption in mg
2. QOR-15 score at postoperative day 1 and postoperative day 3
3. Postoperative rescue fentanyl requirements in mcg in the first 48 hours
4. Numeric Rating Scale (NRS)
5. Modified Ramsay Sedation Score
6. NRS on first ambulation
7. NRS on coughing
8. Postoperative respiratory depression
9. Time to enteric resumption
10. Time to ambulation
11. Time to flatus pass
12. Postoperative nausea and vomiting at the above mentioned time points
13. Postoperative pruritus at the above mentioned time points
14. Patient satisfaction score
15. Length of hospital stay
 
At rest on arrival at the ICU (T0); 3 hours (T1); 6 hours (T2); 12 hours (T3); 24 hours(T4); 48 hours (T5); 72 hours (T6)
 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The modified Makuuchi incision involves a vertical midline cut that meets a horizontal incision at the umbilical level involving T6-T10 dermatomes. The horizontal incision takes a reversed L-shape, following the contour of the abdominal skinfold, ending at the midpoint between the lowest rib and the anterior superior iliac spine. This incision is often employed for upper abdominal surgeries like radical cholecystectomy, hepatectomy, Whipple’s procedure and radical nephrectomy. The institutional practice is to give bilateral oblique subcostal TAP block in these surgeries for postoperative analgesia as a part of an enhanced recovery protocol. This blocks the anterior cutaneous branches but spares the lateral cutaneous branches of T6-T10 intercostal nerves and hence does not cover the

horizontal part of the incision. The external oblique intercostal block (EOIB),initially described by Elsharkawy et al, is a novel fascial plane block indicated for upper abdominal

procedures. It blocks the anterior and lateral cutaneous branches of the T6–T10 intercostal nerves and can be performed easily under ultrasound guidance due to the superficial location of the fascial plane between the external oblique and intercostal muscles. To our knowledge, analgesic efficacy of EOIB vs OSTAP in surgeries involving modified Makuuchi

incision has not been investigated yet in a randomised controlled trial. So, this single centre, randomised, double-blind controlled trial has been designed to investigate the analgesic

efficacy of EOIB vs OSTAP in surgeries involving modified Makuuchi incision. 35 patients will be analysed in each group. Eligible patients undergoing elective abdominal surgeries with modified Makuuchi incision or reversed L- shaped incision will be included in our study. Our primary outcome is the 24 hour postoperative morphine consumption, while secondary outcomes include 48-hours and 72-hours intravenous morphine consumption in mg, QOR-15 score at postoperative day 1 and postoperative day 3, Postoperative rescue fentanyl requirements in mcg in the first 48 hours, Numeric Rating Scale (NRS) of static and dynamic pain, Modified Ramsay Sedation Score at various time intervals, complications like postoperative respiratory depression, PONV, pruritus, time to enteric resumption, ambulation and flatus pass, patient satisfaction score, length of hospital stay.


 
Close